E. Abemayor and N. Sidell, Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation, Environmental Health Perspectives, vol.80, pp.3-15, 1989.
DOI : 10.1289/ehp.89803

E. Abreu, E. Aritonovska, P. Reichenbach, G. Cristofari, B. Culp et al., TIN2-Tethered TPP1 Recruits Human Telomerase to Telomeres In Vivo, Molecular and Cellular Biology, vol.30, issue.12, pp.2971-2982, 2010.
DOI : 10.1128/MCB.00240-10

A. Acheson, J. C. Conover, J. P. Fandl, T. M. Dechiara, M. Russell et al., A BDNF autocrine loop in adult sensory neurons prevents cell death, Nature, vol.374, issue.6521, pp.450-453, 1995.
DOI : 10.1038/374450a0

S. Ahmed, J. F. Passos, M. J. Birket, T. Beckmann, S. Brings et al., Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress, Journal of Cell Science, vol.121, issue.7, pp.1046-1053, 2008.
DOI : 10.1242/jcs.019372

M. Akiyama, T. Hideshima, T. Hayashi, Y. T. Tai, C. S. Mitsiades et al., Nuclear factorkappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein, Cancer research, vol.63, pp.18-21, 2003.

J. Albanell, W. Han, B. Mellado, R. Gunawardane, H. I. Scher et al., Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines, Cancer research, vol.56, pp.1503-1508, 1996.

R. C. Allsopp, E. Chang, M. Kashefi-aazam, E. I. Rogaev, M. A. Piatyszek et al., Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo, Experimental Cell Research, vol.220, issue.1, pp.194-200, 1995.
DOI : 10.1006/excr.1995.1306

I. M. Ambros, S. Rumpler, A. Luegmayr, C. M. Hattinger, S. Strehl et al., Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation???sign of tumour cell revertance?, European Journal of Cancer, vol.33, issue.12, pp.2043-2049, 1997.
DOI : 10.1016/S0959-8049(97)00204-9

K. Arai, K. Masutomi, S. Khurts, S. Kaneko, K. Kobayashi et al., Two Independent Regions of Human Telomerase Reverse Transcriptase Are Important for Its Oligomerization and Telomerase Activity, Journal of Biological Chemistry, vol.277, issue.10, pp.8538-8544, 2002.
DOI : 10.1074/jbc.M111068200

B. N. Armbruster, S. S. Banik, C. Guo, A. C. Smith, and C. M. Counter, N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo, Molecular and Cellular Biology, vol.21, issue.22, pp.7775-7786, 2001.
DOI : 10.1128/MCB.21.22.7775-7786.2001

L. Armstrong, G. Saretzki, H. Peters, I. Wappler, J. Evans et al., Overexpression of Telomerase Confers Growth Advantage, Stress Resistance, and Enhanced Differentiation of ESCs Toward the Hematopoietic Lineage, Stem Cells, vol.275, issue.4, pp.516-529, 2005.
DOI : 10.1634/stemcells.2004-0269

S. E. Artandi, S. Alson, M. K. Tietze, N. E. Sharpless, S. Ye et al., Constitutive telomerase expression promotes mammary carcinomas in aging mice, Proceedings of the National Academy of Sciences of the United States of America 99, pp.8191-8196, 2002.
DOI : 10.1073/pnas.112515399

A. Ashkenazi and V. M. Dixit, Death Receptors: Signaling and Modulation, Science, vol.281, issue.5381, pp.1305-1308, 1998.
DOI : 10.1126/science.281.5381.1305

S. P. Atkinson, S. F. Hoare, R. M. Glasspool, K. , and W. N. , Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters, Cancer research, vol.65, pp.7585-7590, 2005.

A. Azouz, Y. L. Wu, J. Hillion, I. Tarkanyi, A. Karniguian et al., Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells, Leukemia, vol.3, issue.3, pp.613-622, 2010.
DOI : 10.1016/S0006-291X(02)02775-4

F. Bachand and C. Autexier, Functional Regions of Human Telomerase Reverse Transcriptase and Human Telomerase RNA Required for Telomerase Activity and RNA-Protein Interactions, Molecular and Cellular Biology, vol.21, issue.5, pp.1888-1897, 2001.
DOI : 10.1128/MCB.21.5.1888-1897.2001

R. E. Bachelder, M. A. Wendt, N. Fujita, T. Tsuruo, and A. M. Mercurio, The Cleavage of Akt/Protein Kinase B by Death Receptor Signaling Is an Important Event in Detachment-induced Apoptosis, Journal of Biological Chemistry, vol.276, issue.37, pp.34702-34707, 2001.
DOI : 10.1074/jbc.M102806200

S. A. Bader, C. Fasching, G. M. Brodeur, and E. J. Stanbridge, Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells, Cell Growth Differ, vol.2, pp.245-255, 1991.

S. Bagheri, M. Nosrati, S. Li, S. Fong, S. Torabian et al., Genes and pathways downstream of telomerase in melanoma metastasis, Proceedings of the National Academy of Sciences of the United States of America, pp.11306-11311, 2006.
DOI : 10.1073/pnas.0510085103

W. C. Hahn, C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks et al., Creation of human tumour cells with defined genetic elements, Nature, vol.400, pp.464-468, 1999.

W. C. Hahn, S. A. Stewart, M. W. Brooks, S. G. York, E. Eaton et al., Inhibition of telomerase limits the growth of human cancer cells, Nature medicine, vol.5, pp.1164-1170, 1999.

V. Hakin-smith, D. A. Jellinek, D. Levy, T. Carroll, M. Teo et al., Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme, The Lancet, vol.361, issue.9360, pp.836-838, 2003.
DOI : 10.1016/S0140-6736(03)12681-5

L. M. Hansford, A. E. Mckee, L. Zhang, R. E. George, J. T. Gerstle et al., Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell, Cancer Research, vol.67, issue.23, pp.11234-11243, 2007.
DOI : 10.1158/0008-5472.CAN-07-0718

C. B. Harley, A. B. Futcher, and C. W. Greider, Telomeres shorten during ageing of human fibroblasts, Nature, vol.345, issue.6274, pp.458-460, 1990.
DOI : 10.1038/345458a0

C. B. Harley, H. Vaziri, C. M. Counter, A. , and R. C. , The telomere hypothesis of cellular aging, Experimental Gerontology, vol.27, issue.4, pp.375-382, 1992.
DOI : 10.1016/0531-5565(92)90068-B

L. Harrington, Those dam-aged telomeres!, Current Opinion in Genetics & Development, vol.14, issue.1, pp.22-28, 2004.
DOI : 10.1016/j.gde.2003.12.007

L. Harrington, T. Mcphail, V. Mar, W. Zhou, R. Oulton et al., A Mammalian Telomerase-Associated Protein, Science, vol.275, issue.5302, pp.973-977, 1997.
DOI : 10.1126/science.275.5302.973

L. A. Harrington and C. W. Greider, Telomerase primer specificity and chromosome healing, Nature, vol.353, issue.6343, pp.451-454, 1991.
DOI : 10.1038/353451a0

N. D. Hastie, M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green et al., Telomere reduction in human colorectal carcinoma and with ageing, Nature, vol.346, issue.6287, pp.866-868, 1990.
DOI : 10.1038/346866a0

Y. Hayashi, N. Kanda, T. Inaba, R. Hanada, N. Nagahara et al., Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1, Cancer, vol.47, issue.1, pp.126-132, 1989.
DOI : 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z

L. Hayflick, The Limited in Vitro Lifetime of Human Diploid Cell Strains, pp.614-636, 1965.

N. S. Heiss, S. W. Knight, T. J. Vulliamy, S. M. Klauck, S. Wiemann et al., X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions, Nature Genetics, vol.84, issue.1, pp.32-38, 1998.
DOI : 10.1016/0076-6879(93)18026-9

E. R. Henderson, M. Moore, M. , and B. A. , Telomere G-strand structure and function analyzed by chemical protection, base analog substitution, and utilization by telomerase in vitro, Biochemistry, vol.29, issue.3, pp.732-737, 1990.
DOI : 10.1021/bi00455a020

J. D. Henson, J. A. Hannay, S. W. Mccarthy, J. A. Royds, T. R. Yeager et al., A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas, Clin Cancer Res, vol.11, pp.217-225, 2005.

J. D. Henson, A. A. Neumann, T. R. Yeager, and R. R. Reddel, Alternative lengthening of telomeres in mammalian cells, Oncogene, vol.25, issue.4, pp.598-610, 2002.
DOI : 10.1038/sj.onc.1205058

A. Herbst, S. E. Salghetti, S. Y. Kim, and W. P. Tansey, Multiple cell-type-specific elements regulate Myc protein stability, Oncogene, vol.23, issue.21, pp.3863-3871, 2004.
DOI : 10.1038/sj.onc.1207492

J. A. Hickman, Apoptosis induced by anticancer drugs, Cancer and Metastasis Review, vol.47, issue.2, pp.121-139, 1992.
DOI : 10.1007/BF00048059

C. Hirschmann-jax, A. E. Foster, G. G. Wulf, J. G. Nuchtern, T. W. Jax et al., A distinct "side population" of cells with high drug efflux capacity in human tumor cells, Proceedings of the National Academy of Sciences of the United States of America, pp.14228-14233, 2004.
DOI : 10.1073/pnas.0400067101

E. Hiyama, K. Hiyama, K. Ohtsu, H. Yamaoka, T. Ichikawa et al., Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?, European Journal of Cancer, vol.33, issue.12, pp.1932-1936, 1997.
DOI : 10.1016/S0959-8049(97)00226-8

E. Hiyama, K. Hiyama, T. Yokoyama, T. Ichikawa, and Y. Matsuura, Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics, Japanese Journal of Cancer Research, vol.59, issue.2, pp.159-164, 1992.
DOI : 10.1111/j.1349-7006.1992.tb00081.x

E. Hiyama, K. Hiyama, T. Yokoyama, Y. Matsuura, M. A. Piatyszek et al., Correlating telomerase activity levels with human neuroblastoma outcomes, Nature Medicine, vol.66, issue.3, pp.249-255, 1995.
DOI : 10.1016/S0140-6736(94)92834-7

R. Ho, A. Eggert, T. Hishiki, J. E. Minturn, N. Ikegaki et al., Resistance to chemotherapy mediated by TrkB in neuroblastomas, Cancer research, vol.62, pp.6462-6466, 2002.

D. Hockemeyer, J. P. Daniels, H. Takai, and T. De-lange, Recent Expansion of the Telomeric Complex in Rodents: Two Distinct POT1 Proteins Protect Mouse Telomeres, Cell, vol.126, issue.1, pp.63-77, 2006.
DOI : 10.1016/j.cell.2006.04.044

M. D. Hogarty, The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification, Cancer Letters, vol.197, issue.1-2, pp.173-179, 2003.
DOI : 10.1016/S0304-3835(03)00103-4

S. E. Holt, D. L. Aisner, J. Baur, V. M. Tesmer, M. Dy et al., Functional requirement of p23 and Hsp90 in telomerase complexes, Genes & Development, vol.13, issue.7, pp.817-826, 1999.
DOI : 10.1101/gad.13.7.817

S. E. Holt, V. V. Glinsky, A. B. Ivanova, and G. V. Glinsky, Resistance to apoptosis in human cells conferred by telomerase function and telomere stability, Molecular Carcinogenesis, vol.56, issue.4, pp.241-248, 1999.
DOI : 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2-9

I. Horikawa, P. L. Cable, C. Afshari, and J. C. Barrett, Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene, Cancer research, vol.59, pp.826-830, 1999.

G. Hosoi, J. Hara, T. Okamura, Y. Osugi, S. Ishihara et al., Low frequency of the p53 gene mutations in neuroblastoma, Cancer, vol.64, issue.12, pp.3087-3093, 1994.
DOI : 10.1002/1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9

A. Hotti, K. Jarvinen, P. Siivola, and E. Holtta, Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases, Oncogene, vol.19, issue.19, pp.2354-2362, 2000.
DOI : 10.1038/sj.onc.1203567

B. R. Houghtaling, L. Cuttonaro, W. Chang, and S. Smith, A Dynamic Molecular Link between the Telomere Length Regulator TRF1 and the Chromosome End Protector TRF2, Current Biology, vol.14, issue.18, pp.1621-1631, 2004.
DOI : 10.1016/j.cub.2004.08.052

M. E. Huang, Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu et al., Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Z.Y. Blood, vol.72, pp.567-572, 1988.

F. H. Igney and P. H. Krammer, DEATH AND ANTI-DEATH: TUMOUR RESISTANCE TO APOPTOSIS, Nature Reviews Cancer, vol.2, issue.4, pp.277-288, 2002.
DOI : 10.1038/nrc776

H. Ikeda, J. Hirato, M. Akami, S. Matsuyama, N. Suzuki et al., Bcl-2 oncoprotein expression and apoptosis in neuroblastoma, Journal of Pediatric Surgery, vol.30, issue.6, pp.805-808, 1995.
DOI : 10.1016/0022-3468(95)90752-1

S. Ruchaud, N. Korfali, P. Villa, T. J. Kottke, C. Dingwall et al., Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation, The EMBO Journal, vol.21, issue.8, pp.1967-1977, 2002.
DOI : 10.1093/emboj/21.8.1967

W. Sadee, V. C. Yu, M. L. Richards, P. N. Preis, M. R. Schwab et al., Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line, Cancer research, vol.47, pp.5207-5212, 1987.

G. S. Salvesen and C. S. Duckett, Apoptosis: IAP proteins: blocking the road to death's door, Nature Reviews Molecular Cell Biology, vol.22, issue.6, pp.401-410, 2002.
DOI : 10.1038/nrm830

J. H. Santos, L. Hunakova, Y. Chen, C. Bortner, V. Houten et al., Cell Sorting Experiments Link Persistent Mitochondrial DNA Damage with Loss of Mitochondrial Membrane Potential and Apoptotic Cell Death, Journal of Biological Chemistry, vol.278, issue.3, pp.1728-1734, 2003.
DOI : 10.1074/jbc.M208752200

J. H. Santos, J. N. Meyer, V. Houten, and B. , Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis, Human Molecular Genetics, vol.15, issue.11, pp.1757-1768, 2006.
DOI : 10.1093/hmg/ddl098

G. Saretzki, A. Ludwig, T. Von-zglinicki, R. , and I. B. , Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells, Cancer Gene Therapy, vol.8, issue.10, pp.827-834, 2001.
DOI : 10.1038/sj.cgt.7700383

K. Y. Sarin, P. Cheung, D. Gilison, E. Lee, R. I. Tennen et al., Conditional telomerase induction causes proliferation of hair follicle stem cells, Nature, vol.436, issue.7053, pp.1048-1052, 2005.
DOI : 10.1038/nature03836

J. Sarthy, N. S. Bae, J. Scrafford, and P. Baumann, Human RAP1 inhibits nonhomologous end joining at telomeres. The EMBO journal 28, pp.3390-3399, 2009.
DOI : 10.1038/emboj.2009.275

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776107

S. Sato, N. Fujita, and T. Tsuruo, Modulation of Akt kinase activity by binding to Hsp90, Proceedings of the National Academy of Sciences, vol.97, issue.20, pp.10832-10837, 2000.
DOI : 10.1073/pnas.170276797

G. Schleiermacher, O. Delattre, M. Peter, V. Mosseri, P. Delonlay et al., Clinical relevance of loss of heterozygosity of the short arm of chromosome 1 in neuroblastoma: A single-institution study, International Journal of Cancer, vol.3, issue.2, pp.73-78, 1996.
DOI : 10.1002/(SICI)1097-0215(19960422)69:2<73::AID-IJC1>3.0.CO;2-S

G. Schleiermacher, H. Rubie, O. Hartmann, C. Bergeron, P. Chastagner et al., Treatment of stage 4s neuroblastoma ??? report of 10 years' experience of the French Society of Paediatric Oncology (SFOP), British Journal of Cancer, vol.89, issue.3, pp.470-476, 2003.
DOI : 10.1038/sj.bjc.6601154

M. L. Schmidt, J. N. Lukens, R. C. Seeger, G. M. Brodeur, H. Shimada et al., Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children???s Cancer Group Study, Journal of Clinical Oncology, vol.18, issue.6, pp.1260-1268, 2000.
DOI : 10.1200/JCO.2000.18.6.1260

M. Schwab, K. Alitalo, K. H. Klempnauer, H. E. Varmus, J. M. Bishop et al., Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour, Nature, vol.79, issue.5931, pp.245-248, 1983.
DOI : 10.1038/305245a0

M. Schwab, H. E. Varmus, J. M. Bishop, K. H. Grzeschik, S. L. Naylor et al., Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc, Nature, vol.35, issue.5956, pp.288-291, 1984.
DOI : 10.1038/308288a0

R. C. Sears, The Life Cycle of C-Myc: From Synthesis to Degradation, Cell Cycle, vol.3, issue.9, pp.1133-1137, 2004.
DOI : 10.4161/cc.3.9.1145

R. C. Seeger, G. M. Brodeur, H. Sather, A. Dalton, S. E. Siegel et al., Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, pp.1111-1116, 1985.

R. C. Seeger, R. Wada, G. M. Brodeur, T. J. Moss, R. L. Bjork et al., Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene, Progress in clinical and biological research, pp.41-49, 1988.

E. Segal-bendirdjian, J. Hillion, and C. A. Belmokhtar, [Current concepts on apoptotic signalling pathways: new targets for anticancer strategies], Bulletin du cancer, vol.90, pp.9-17, 2003.

H. Seimiya, H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko et al., Involvement of 14-3-3 proteins in nuclear localization of telomerase, The EMBO Journal, vol.19, issue.11, 2000.
DOI : 10.1093/emboj/19.11.2652

A. Sfeir, S. Kabir, M. Van-overbeek, G. B. Celli, and T. De-lange, Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal, Science, vol.327, issue.5973, pp.1657-1661, 2010.
DOI : 10.1126/science.1185100

A. Sfeir, S. T. Kosiyatrakul, D. Hockemeyer, S. L. Macrae, J. Karlseder et al., Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication, Cell, vol.138, issue.1, pp.90-103, 2009.
DOI : 10.1016/j.cell.2009.06.021

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723738/pdf

G. G. Sharma, A. Gupta, H. Wang, H. Scherthan, S. Dhar et al., hTERT associates with human telomeres and enhances genomic stability and DNA repair, Oncogene, vol.22, issue.1, pp.131-146, 2003.
DOI : 10.1038/sj.onc.1206063

H. W. Sharma, J. A. Sokoloski, J. R. Perez, J. Y. Maltese, A. C. Sartorelli et al., Differentiation of immortal cells inhibits telomerase activity., Proceedings of the National Academy of Sciences of the United States of America 92, pp.12343-12346, 1995.
DOI : 10.1073/pnas.92.26.12343

N. E. Sharpless, The Persistence of Senescence, Science of Aging Knowledge Environment, vol.2003, issue.33, p.24, 2003.
DOI : 10.1126/sageke.2003.33.pe24

N. E. Sharpless and R. A. Depinho, Telomeres, stem cells, senescence, and cancer, Journal of Clinical Investigation, vol.113, issue.2, pp.160-168, 2004.
DOI : 10.1172/JCI20761

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC311439

J. W. Shay, At the end of the millennium, a view of the end, Nature Genetics, vol.23, issue.4, pp.382-383, 1999.
DOI : 10.1038/70480

J. W. Shay, B. A. Van-der-haegen, Y. Ying, W. , and W. E. , The Frequency of Immortalization of Human Fibroblasts and Mammary Epithelial Cells Transfected with SV40 Large T-Antigen, Experimental Cell Research, vol.209, issue.1, pp.45-52, 1993.
DOI : 10.1006/excr.1993.1283

J. W. Shay, W. , and W. E. , Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen, Experimental Cell Research, vol.184, issue.1, pp.109-118, 1989.
DOI : 10.1016/0014-4827(89)90369-8

H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi et al., The International Neuroblastoma Pathology Classification (the Shimada system), Cancer, vol.334, issue.2, pp.364-372, 1999.
DOI : 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7

N. Shimizu, H. Nakamura, T. Kadota, K. Kitajima, T. Oda et al., Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells, Cancer research, vol.54, pp.3561-3567, 1994.

K. H. Shin, M. K. Kang, E. Dicterow, and N. H. Park, Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes, British Journal of Cancer, vol.89, issue.8, pp.1473-1478, 2003.
DOI : 10.1038/sj.bjc.6601291

T. Shojaei-brosseau, A. Chompret, A. Abel, F. De-vathaire, M. A. Raquin et al., Genetic epidemiology of Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway, The Journal of biological chemistry, vol.280, pp.22776-22787, 2004.

J. Wang, G. J. Hannon, and D. H. Beach, Risky immortalization by telomerase, Nature, vol.405, pp.755-756, 2000.

J. Wang, L. Y. Xie, S. Allan, D. Beach, and G. J. Hannon, Myc activates telomerase, Genes & Development, vol.12, issue.12, pp.1769-1774, 1998.
DOI : 10.1101/gad.12.12.1769

S. Wang and J. Zhu, Evidence for a Relief of Repression Mechanism for Activation of the Human Telomerase Reverse Transcriptase Promoter, Journal of Biological Chemistry, vol.278, issue.21, pp.18842-18850, 2003.
DOI : 10.1074/jbc.M209544200

N. J. Waterhouse, D. M. Finucane, D. R. Green, J. S. Elce, S. Kumar et al., Calpain activation is upstream of caspases in radiation-induced apoptosis, Cell Death and Differentiation, vol.5, issue.12, pp.1051-1061, 1998.
DOI : 10.1038/sj.cdd.4400425

N. J. Waterhouse, K. A. Sedelies, K. A. Browne, M. E. Wowk, A. Newbold et al., A Central Role for Bid in Granzyme B-induced Apoptosis, Journal of Biological Chemistry, vol.280, issue.6, pp.4476-4482, 2005.
DOI : 10.1074/jbc.M410985200

J. D. Watson, Origin of Concatemeric T7DNA, Nature New Biology, vol.239, issue.94, pp.197-201, 1972.
DOI : 10.1038/newbio239197a0

S. L. Weinrich, R. Pruzan, L. Ma, M. Ouellette, V. M. Tesmer et al., Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT, Nature Genetics, vol.228, issue.4, pp.498-502, 1997.
DOI : 10.1038/ng1297-498

W. A. Weiss, K. Aldape, G. Mohapatra, B. G. Feuerstein, and J. M. Bishop, Targeted expression of MYCN causes neuroblastoma in transgenic mice, The EMBO Journal, vol.16, issue.11, pp.2985-2995, 1997.
DOI : 10.1093/emboj/16.11.2985

A. Wenzel and M. Schwab, The mycn/max protein complex in neuroblastoma. Short review, European Journal of Cancer, vol.31, issue.4, pp.516-519, 1995.
DOI : 10.1016/0959-8049(95)00060-V

F. Westermann and M. Schwab, Genetic parameters of neuroblastomas, Cancer Letters, vol.184, issue.2, pp.127-147, 2002.
DOI : 10.1016/S0304-3835(02)00199-4

A. Ebeling, Age and multiplication of fibroblasts, J Exp Med, vol.34, pp.599-606, 1921.

L. Hayflick and P. Moorhead, The serial cultivation of human diploid cell strains, Experimental Cell Research, vol.25, issue.3, pp.585-621, 1961.
DOI : 10.1016/0014-4827(61)90192-6

J. Campisi, Replicative senescence and immortalization In The molecular basis of cell cycle and growth control, pp.348-373

G. Dimri, X. Lee, and G. Basile, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9367, 1995.
DOI : 10.1073/pnas.92.20.9363

J. Going, R. Stuart, M. Downie, A. Fletcher-monaghan, and W. Keith, ?Senescence-associated? ?-galactosidase activity in the upper gastrointestinal tract, The Journal of Pathology, vol.219, issue.4, pp.394-400, 2002.
DOI : 10.1002/path.1059

V. Cristofalo, C. Volker, M. Francis, and M. Tresini, Age-Dependent Modifications of Gene Expression in Human Fibroblasts, Critical Reviews?? in Eukaryotic Gene Expression, vol.8, issue.1, pp.43-80, 1998.
DOI : 10.1615/CritRevEukarGeneExpr.v8.i1.30

J. Campisi, Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors, Cell, vol.120, issue.4, pp.513-522, 2005.
DOI : 10.1016/j.cell.2005.02.003

URL : http://doi.org/10.1016/j.cell.2005.02.003

O. Toussaint, J. Remacle, and J. Dierick, Stress-induced premature senescence: from biomarkers to likeliness of in vivo occurrence, Biogerontology, vol.3, issue.1/2, pp.13-17, 2002.
DOI : 10.1023/A:1015226524335

J. Shay, O. Pereira-smith, and W. Wright, A role for both RB and p53 in the regulation of human cellular senescence*1, Experimental Cell Research, vol.196, issue.1, pp.33-39, 1991.
DOI : 10.1016/0014-4827(91)90453-2

A. Lundberg, W. Hahn, P. Gupta, and R. Weinberg, Genes involved in senescence and immortalization, Current Opinion in Cell Biology, vol.12, issue.6, pp.705-709, 2000.
DOI : 10.1016/S0955-0674(00)00155-1

B. Mcclintock, The stability of broken ends of chromosomes in Zea mays, Genetics, vol.26, pp.234-282, 1941.

H. Muller, The remaking of chromosomes. Collect Net, pp.181-195, 1938.

R. Moyzis, J. Buckingham, and L. Cram, A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes., Proceedings of the National Academy of Sciences, vol.85, issue.18, pp.6622-6626, 1988.
DOI : 10.1073/pnas.85.18.6622

J. Watson, Origin of Concatemeric T7DNA, Nature New Biology, vol.239, issue.94, pp.197-201, 1972.
DOI : 10.1038/newbio239197a0

A. Olovnikov, Principle of marginotomy in template synthesis of polynucleotides], Dokl Akad Nauk SSSR, vol.201, pp.1496-1499, 1971.

A. Olovnikov, A theory of marginotomy, Journal of Theoretical Biology, vol.41, issue.1, pp.181-190, 1973.
DOI : 10.1016/0022-5193(73)90198-7

W. Wright and J. Shay, Cellular senescence as a tumor-protection mechanism: the essential role of counting, Current Opinion in Genetics & Development, vol.11, issue.1, pp.98-103, 2001.
DOI : 10.1016/S0959-437X(00)00163-5

C. Greider and E. Blackburn, Identification of a specific telomere terminal transferase activity in tetrahymena extracts, Cell, vol.43, issue.2, pp.405-413, 1985.
DOI : 10.1016/0092-8674(85)90170-9

J. Feng, W. Funk, and S. Wang, The RNA component of human telomerase, Science, vol.269, issue.5228, pp.1236-1241, 1995.
DOI : 10.1126/science.7544491

T. Nakamura, G. Morin, and K. Chapman, Telomerase catalytic subunit homologs from fission yeast and human al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity, Science Counter CM Embo J, vol.277, issue.11, pp.955-9591921, 1992.
DOI : 10.1126/science.277.5328.955

N. Kim, M. Piatyszek, and K. Prowse, Specific association of human telomerase activity with immortal cells and cancer, Science, vol.266, issue.5193, pp.2011-2015, 1994.
DOI : 10.1126/science.7605428

W. Wright, M. Piatyszek, W. Rainey, W. Byrd, and J. Shay, Telomerase activity in human germline and embryonic tissues and cells, Developmental Genetics, vol.23, issue.2, pp.173-179, 1996.
DOI : 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3

C. Chiu and C. Harley, Replicative Senescence and Cell Immortality: The Role of Telomeres and Telomerase, Experimental Biology and Medicine, vol.214, issue.2, pp.99-106, 1997.
DOI : 10.3181/00379727-214-44075

A. Bodnar, M. Ouellette, and M. Frolkis, Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science, vol.279, issue.5349, pp.349-352, 1998.
DOI : 10.1126/science.279.5349.349

X. Jiang, G. Jimenez, and E. Chang, Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype, Nature Genetics, vol.21, issue.1, pp.111-114, 1999.
DOI : 10.1038/5056

C. Morales, S. Holt, and M. Ouellette, Absence of cancer-associated changes in human fibroblasts immortalized with telomerase, Nature Genetics, vol.21, issue.1, pp.115-118, 1999.
DOI : 10.1038/5063

W. Funk, C. Wang, and D. Shelton, Telomerase Expression Restores Dermal Integrity to in Vitro-Aged Fibroblasts in a Reconstituted Skin Model, Experimental Cell Research, vol.258, issue.2, pp.270-278, 2000.
DOI : 10.1006/excr.2000.4945

C. Counter, M. Meyerson, and E. Eaton, Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase, Oncogene, vol.16, issue.9, pp.1217-1222, 1998.
DOI : 10.1038/sj.onc.1201882

M. Blasco, H. Coller, and J. Roberts, Opinion: Telomerase beyond telomeres, Nature Reviews Cancer, vol.2, issue.8, pp.627-633474, 2002.
DOI : 10.1038/nrc862

H. Xiang, J. Wang, and Y. Mao, Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway, Oncogene, vol.21, issue.23, pp.3784-3791, 2002.
DOI : 10.1038/sj.onc.1205455

C. Geserick, A. Tejera, E. Gonzalez-suarez, P. Klatt, and M. Blasco, Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-?? signaling, Oncogene, vol.23, issue.31, pp.4310-4319, 2006.
DOI : 10.1038/sj.onc.1209465

C. Dudognon, F. Pendino, and J. Hillion, Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance, Oncogene, vol.23, issue.45, pp.7469-7474, 2004.
DOI : 10.1038/sj.onc.1208029

T. Bryan, A. Englezou, J. Gupta, S. Bacchetti, and R. Reddel, Telomere elongation in immortal human cells without detectable telomerase activity, Embo J, vol.14, pp.4240-4248, 1995.

M. Dunham, A. Neumann, C. Fasching, and R. Reddel, Telomere maintenance by recombination in human cells, Nat Genet, vol.26, pp.447-450, 2000.

A. Muntoni and R. Reddel, The first molecular details of ALT in human tumor cells, Human Molecular Genetics, vol.14, issue.suppl_2, pp.191-196, 2005.
DOI : 10.1093/hmg/ddi266

J. Griffith, L. Comeau, and S. Rosenfield, Mammalian Telomeres End in a Large Duplex Loop, Cell, vol.97, issue.4, pp.503-514, 1999.
DOI : 10.1016/S0092-8674(00)80760-6

D. Liu, O. Connor, M. Qin, J. Songyang, and Z. , Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins Shelterin: the protein complex that shapes and safeguards human telomeres Control of telomere length by the human telomeric protein TRF1, J Biol Chem Genes Dev Nature, vol.279, issue.385, pp.51338-513422100, 1997.

B. Van-steensel, A. Smogorzewska, T. De-lange, S. Teo, and S. Jackson, TRF2 protects human telomeres from end-toend fusions Functional links between telomeres and proteins of the DNA-damage response, Cell Genes Dev, vol.92, issue.18, pp.401-4131781, 1998.

E. Blackburn, Telomere states and cell fates, Nature, vol.408, issue.6808, pp.53-56, 2000.
DOI : 10.1038/35040500

T. De-lange, CELL BIOLOGY: Enhanced: Telomere Capping--One Strand Fits All, Science, vol.292, issue.5519, pp.1075-1076, 2001.
DOI : 10.1126/science.1061032

J. Karlseder, D. Broccoli, Y. Dai, S. Hardy, and T. De-lange, p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2, Science, vol.283, issue.5406, pp.1321-1325, 1999.
DOI : 10.1126/science.283.5406.1321

J. Karlseder, A. Smogorzewska, and T. De-lange, Senescence Induced by Altered Telomere State, Not Telomere Loss, Science, vol.295, issue.5564, pp.2446-2449, 2002.
DOI : 10.1126/science.1069523

K. Masutomi, E. Yu, and S. Khurts, Telomerase maintains telomere structure in normal human cells Human cell senescence as a DNA damage response, Cell Mech Ageing Dev, vol.114, issue.126, pp.241-253111, 2003.

J. Lowell and L. Pillus, Telomere tales: chromatin, telomerase and telomere function in Saccharomyces cerevisiae, Cellular and Molecular Life Sciences (CMLS), vol.54, issue.1, pp.32-49, 1998.
DOI : 10.1007/s000180050123

V. Lundblad and J. Szostak, A mutant with a defect in telomere elongation leads to senescence in yeast, Cell, vol.57, issue.4, pp.633-643, 1989.
DOI : 10.1016/0092-8674(89)90132-3

S. Ahmed and J. Hodgkin, MRT-2 checkpoint protein is required for germline immortality and telomere replication in C. elegans, Nature, vol.403, issue.6766, pp.159-164, 2000.
DOI : 10.1038/35003120

M. Blasco, H. Lee, and M. Hande, Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA, Cell, vol.91, issue.1, pp.25-34, 1997.
DOI : 10.1016/S0092-8674(01)80006-4

K. Rudolph, S. Chang, and H. Lee, Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice, Cell, vol.96, issue.5, pp.701-712, 1999.
DOI : 10.1016/S0092-8674(00)80580-2

J. Bartkova, Z. Horejsi, and K. Koed, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, vol.10, issue.7035, pp.864-870, 2005.
DOI : 10.1093/bioinformatics/14.9.755

V. Gorgoulis, L. Vassiliou, and P. Karakaidos, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature, vol.159, issue.7035, pp.907-913, 2005.
DOI : 10.1038/nm0696-682

T. Kiyono, S. Foster, and J. Koop, Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells, Nature, vol.396, pp.84-88, 1998.

Q. Chen, A. Fischer, J. Reagan, L. Yan, and B. Ames, Oxidative DNA damage and senescence of human diploid fibroblast cells., Proceedings of the National Academy of Sciences, vol.92, issue.10, pp.4337-4341, 1995.
DOI : 10.1073/pnas.92.10.4337

M. Serrano, A. Lin, M. Mccurrach, D. Beach, and S. Lowe, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell, vol.88, issue.5, pp.593-602, 1997.
DOI : 10.1016/S0092-8674(00)81902-9

G. Ferbeyre, E. De-stanchina, and A. Lin, Oncogenic ras and p53 Cooperate To Induce Cellular Senescence, Molecular and Cellular Biology, vol.22, issue.10, pp.3497-3508, 2002.
DOI : 10.1128/MCB.22.10.3497-3508.2002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC133786

C. Brack, G. Lithgow, H. Osiewacz, O. Toussaint, . Embo et al., EMBO WORKSHOP REPORT: Molecular and cellular gerontology Serpiano, Switzerland, September 18-22, 1999, The EMBO Journal, vol.19, issue.9, pp.1929-1934, 1999.
DOI : 10.1093/emboj/19.9.1929

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC305699

W. Wright and J. Shay, Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology, Nature Medicine, vol.6, issue.8, pp.849-851, 2000.
DOI : 10.1038/78592

C. Sherr and R. Depinho, Cellular Senescence, Cell, vol.102, issue.4, pp.407-410, 2000.
DOI : 10.1016/S0092-8674(00)00046-5

D. Feldser and C. Greider, Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence, Cancer Cell, vol.11, issue.5, pp.461-469, 2007.
DOI : 10.1016/j.ccr.2007.02.026

W. Cosme-blanco, M. Shen, and A. Lazar, Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence, EMBO reports, vol.27, issue.5, pp.497-503, 2007.
DOI : 10.1016/S0960-9822(03)00542-6

J. Campisi, From cells to organisms: can we learn about aging from cells in culture?, Experimental Gerontology, vol.36, issue.4-6, pp.607-618, 2001.
DOI : 10.1016/S0531-5565(00)00230-8

H. Rubin, The disparity between human cell senescence in vitro and lifelong replication in vivo, Nature Biotechnology, vol.20, issue.7, pp.675-681, 2002.
DOI : 10.1038/nbt0702-675

R. Faragher, Cell senescence and human aging: where's the link?, Biochemical Society Transactions, vol.28, issue.2, pp.221-226, 2000.
DOI : 10.1042/bst0280221

P. Mohaghegh and I. Hickson, DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders, Human Molecular Genetics, vol.10, issue.7, pp.741-746, 2001.
DOI : 10.1093/hmg/10.7.741

A. Krtolica and J. Campisi, Cancer and aging: a model for the cancer promoting effects of the aging stroma, The International Journal of Biochemistry & Cell Biology, vol.34, issue.11, pp.1401-1414, 2002.
DOI : 10.1016/S1357-2725(02)00053-5

K. Rudolph, M. Millard, M. Bosenberg, and R. Depinho, Telomere dysfunction and evolution of intestinal carcinoma in mice and humans, Nature Genetics, vol.28, issue.2, pp.155-159, 2001.
DOI : 10.1038/88871

P. Farazi, J. Glickman, and S. Jiang, Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma, Cancer Res, vol.63, pp.5021-5027, 2003.

O. Sullivan, J. Bronner, M. Brentnall, and T. , Chromosomal instability in ulcerative colitis is related to telomere shortening, Nature Genetics, vol.11, issue.2, pp.280-284, 2002.
DOI : 10.1016/S0092-8674(00)80762-X

S. Wiemann, A. Satyanarayana, and M. Tsahuridu, Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis, The FASEB Journal, vol.16, issue.9, pp.935-942, 2002.
DOI : 10.1096/fj.01-0977com

R. Cawthon, K. Smith, O. Brien, E. Sivatchenko, A. Kerber et al., Association between telomere length in blood and mortality in people aged 60 years or older, The Lancet, vol.361, issue.9355, pp.393-395, 2003.
DOI : 10.1016/S0140-6736(03)12384-7

E. Chang and C. Harley, Telomere length and replicative aging in human vascular tissues., Proceedings of the National Academy of Sciences, vol.92, issue.24, pp.11190-11194, 1995.
DOI : 10.1073/pnas.92.24.11190

E. Epel, J. Lin, and F. Wilhelm, Cell aging in relation to stress arousal and cardiovascular disease risk factors, Psychoneuroendocrinology, vol.31, issue.3, pp.277-287, 2006.
DOI : 10.1016/j.psyneuen.2005.08.011

M. Vasa-nicotera, S. Brouilette, and M. Mangino, Mapping of a Major Locus that Determines Telomere Length in Humans, The American Journal of Human Genetics, vol.76, issue.1, pp.147-151, 2005.
DOI : 10.1086/426734

T. Vulliamy, A. Walne, and A. Baskaradas, Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure, Blood Cells, Molecules, and Diseases, vol.34, issue.3, pp.257-263, 2005.
DOI : 10.1016/j.bcmd.2004.12.008

I. Dokal, . Dyskeratosis-congenita, E. Chavez, and K. Lee, A disease of premature ageing Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts, Lancet Aging Cell, vol.358, issue.6, pp.383-394, 2001.

R. Faragher, I. Kill, and J. Hunter, The gene responsible for Werner syndrome may be a cell division "counting" gene., Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.12030-12034, 1993.
DOI : 10.1073/pnas.90.24.12030

C. Yu, J. Oshima, and Y. Fu, Positional Cloning of the Werner's Syndrome Gene, Science, vol.272, issue.5259, pp.258-262, 1996.
DOI : 10.1126/science.272.5259.258

F. Wyllie, C. Jones, and J. Skinner, Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts, Nat Genet, vol.24, pp.16-17, 2000.

L. Crabbe, A. Jauch, C. Naeger, H. Holtgreve-grez, and J. Karlseder, Telomere dysfunction as a cause of genomic instability in Werner syndrome, Proceedings of the National Academy of Sciences, vol.104, issue.7, pp.2205-2210, 2007.
DOI : 10.1073/pnas.0609410104

D. Baird, T. Davis, J. Rowson, C. Jones, and D. Kipling, Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells, Human Molecular Genetics, vol.13, issue.14, pp.1515-1524, 2004.
DOI : 10.1093/hmg/ddh159

A. Krtolica and J. Campisi, Integrating epithelial cancer, aging stroma and cellular senescence, Adv Gerontol, vol.11, pp.109-116, 2003.

A. Krtolica, S. Parrinello, S. Lockett, P. Desprez, and J. Campisi, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proceedings of the National Academy of Sciences, vol.98, issue.21, pp.121072-112077, 2001.
DOI : 10.1073/pnas.211053698

B. Chang, E. Broude, and M. Dokmanovic, A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents, Cancer Res, vol.59, pp.3761-3767, 1999.

L. Elmore, C. Rehder, and X. Di, Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction, Journal of Biological Chemistry, vol.277, issue.38, pp.35509-35515, 2002.
DOI : 10.1074/jbc.M205477200

F. Pendino, I. Tarkanyi, and C. Dudognon, Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Curr Cancer Drug Targets, pp.147-180, 2006.

F. Pendino, M. Flexor, and F. Delhommeau, Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation, Proceedings of the National Academy of Sciences, vol.98, issue.12, pp.6662-6667, 2001.
DOI : 10.1073/pnas.111464998

F. Pendino, C. Dudognon, and F. Delhommeau, Retinoic acid receptor ?? and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death, Oncogene, vol.22, issue.57, pp.9142-9150, 2003.
DOI : 10.1038/sj.onc.1207093

I. Roninson and M. Dokmanovic, Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids, Journal of Cellular Biochemistry, vol.73, issue.1, pp.83-94, 2003.
DOI : 10.1002/jcb.10320

M. Dokmanovic, B. Chang, J. Fang, and I. Roninson, Retinoid-Induced Growth Arrest of Breast Carcinoma Cells Involves Co-Activation of Multiple Growth-Inhibitory Genes, Cancer Biology & Therapy, vol.1, issue.1, pp.24-27, 2002.
DOI : 10.4161/cbt.1.1.35

Y. Chen, M. Dokmanovic, W. Stein, R. Ardecky, and I. Roninson, Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells, Cancer Research, vol.66, issue.17, pp.8749-8761, 2006.
DOI : 10.1158/0008-5472.CAN-06-0581

R. Vonderheide, S. Domchek, and J. Schultze, Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes, Clinical Cancer Research, vol.10, issue.3, pp.828-839, 2004.
DOI : 10.1158/1078-0432.CCR-0620-3

W. Keith, A. Bilsland, M. Hardie, and T. Evans, Drug Insight: cancer cell immortality???telomerase as a target for novel cancer gene therapies, Nature Clinical Practice Oncology, vol.64, issue.2, pp.88-96, 2004.
DOI : 10.1200/JCO.20.6.1562

I. Tarkanyi, C. Dudognon, and J. Hillion, Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death, Leukemia, vol.117, issue.10, pp.1806-1811, 2005.
DOI : 10.1200/JCO.2005.10.217

M. Fossel, Cell Senescence in Human Aging and Disease, Annals of the New York Academy of Sciences, vol.81, issue.1, pp.14-23, 2002.
DOI : 10.1111/j.1749-6632.2002.tb02078.x

M. Blasco, Telomeres and human disease: ageing, cancer and beyond, Nature Reviews Genetics, vol.12, issue.8, pp.611-622, 2005.
DOI : 10.1016/j.ccr.2004.12.012

J. Shay and W. Wright, The use of telomerized cells for tissue engineering, Nature Biotechnology, vol.18, issue.1, pp.22-23, 2000.
DOI : 10.1038/71872

S. Steinert, D. White, Y. Zou, J. Shay, and W. Wright, Telomere Biology and Cellular Aging in Nonhuman Primate Cells, Experimental Cell Research, vol.272, issue.2, pp.146-152, 2002.
DOI : 10.1006/excr.2001.5409

K. Prowse and C. Greider, Developmental and tissue-specific regulation of mouse telomerase and telomere length., Proceedings of the National Academy of Sciences, vol.92, issue.11, pp.4818-4822, 1995.
DOI : 10.1073/pnas.92.11.4818

T. Fletcher, B. Cathers, K. Ravikumar, B. Mamiya, and S. Kerwin, Inhibition of Human Telomerase by 7-Deaza-2???-deoxyguanosine Nucleoside Triphosphate Analogs: Potent Inhibition by 6-Thio-7-deaza-2???-deoxyguanosine 5???-Triphosphate, Bioorganic Chemistry, vol.29, issue.1, pp.36-55, 2001.
DOI : 10.1006/bioo.2000.1194

C. Strahl and E. Blackburn, Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines., Molecular and Cellular Biology, vol.16, issue.1, pp.53-65, 1996.
DOI : 10.1128/MCB.16.1.53

I. Dixon, F. Lopez, and J. Esteve, Porphyrin Derivatives for Telomere Binding and Telomerase Inhibition, ChemBioChem, vol.12, issue.1, pp.123-132, 2005.
DOI : 10.1002/cbic.200400113

I. Naasani, H. Seimiya, T. Yamori, and T. Tsuruo, FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis, Cancer Res, vol.59, pp.4004-4011, 1999.

K. Damm, U. Hemmann, and P. Garin-chesa, A highly selective telomerase inhibitor limiting human cancer cell proliferation, The EMBO Journal, vol.20, issue.24, pp.6958-6968, 2001.
DOI : 10.1093/emboj/20.24.6958

H. El-daly, M. Kull, and S. Zimmermann, Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532, Blood, vol.105, issue.4, pp.1742-1749, 2005.
DOI : 10.1182/blood-2003-12-4322

K. Kraemer, S. Fuessel, and U. Schmidt, Antisense-mediated hTERT Inhibition Specifically Reduces the Growth of Human Bladder Cancer Cells, Clin Cancer Res, vol.9, pp.3794-3800, 2003.

Y. Yokoyama, Y. Takahashi, and A. Shinohara, The 5???-End of hTERT mRNA Is a Good Target for Hammerhead Ribozyme to Suppress Telomerase Activity, Biochemical and Biophysical Research Communications, vol.273, issue.1, pp.316-321, 2000.
DOI : 10.1006/bbrc.2000.2939

W. Hahn, S. Stewart, and M. Brooks, Inhibition of telomerase limits the growth of human cancer cells, Nat Med, vol.5, pp.1164-1170, 1999.

A. Asai, Y. Oshima, and Y. Yamamoto, A novel telomerase template antagonist (GRN163) as a potential anticancer agent, Cancer Res, vol.63, pp.3931-3939, 2003.

S. Mukai, Y. Kondo, and S. Koga, 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas, Cancer Res, vol.60, pp.4461-4467, 2000.

E. Wang, K. Wu, and A. Chin, Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma, Blood, vol.103, issue.1, pp.258-266, 2004.
DOI : 10.1182/blood-2003-02-0546

I. Tarkanyi, A. Horvath, and I. Szatmari, Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide, FEBS Letters, vol.163, issue.6, pp.1411-1416, 2005.
DOI : 10.1016/j.febslet.2005.01.041

X. Fu, J. Zhang, N. Zhang, and Y. Zhang, Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line, World Journal of Gastroenterology, vol.11, issue.6, pp.785-790, 2005.
DOI : 10.3748/wjg.v11.i6.785

M. Yeo, S. Rha, and H. Jeung, Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells, International Journal of Cancer, vol.8, issue.3, pp.484-489, 2005.
DOI : 10.1002/ijc.20720

Y. Kitagawa, S. Kyo, and M. Takakura, Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT, Clin Cancer Res, vol.6, pp.2868-2875, 2000.

J. Tsurutani, H. Soda, and M. Oka, Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines, International Journal of Cancer, vol.20, issue.2, pp.238-242, 2003.
DOI : 10.1002/ijc.10921

W. Aldous, A. Marean, M. Dehart, L. Matej, and K. Moore, Effects of tamoxifen on telomerase activity in breast carcinoma cell lines, Cancer, vol.45, issue.7, pp.1523-1529, 1999.
DOI : 10.1002/(SICI)1097-0142(19990401)85:7<1523::AID-CNCR13>3.0.CO;2-P

Z. Wang, S. Kyo, and M. Takakura, Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway, Cancer Res, vol.60, pp.5376-5381, 2000.

F. Pendino, J. Hillion, and C. Dudognon, Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL, Leukemia, vol.105, issue.4, pp.599-603, 2006.
DOI : 10.1038/sj.leu.2404127

W. Ku, A. Cheng, and T. Wang, Inhibition of Telomerase Activity by PKC Inhibitors in Human Nasopharyngeal Cancer Cells in Culture, Biochemical and Biophysical Research Communications, vol.241, issue.3, pp.730-736, 1997.
DOI : 10.1006/bbrc.1997.7874

S. Kang, T. Kwon, D. Kwon, and S. Do, Akt Protein Kinase Enhances Human Telomerase Activity through Phosphorylation of Telomerase Reverse Transcriptase Subunit, Journal of Biological Chemistry, vol.274, issue.19, pp.13085-13090, 1999.
DOI : 10.1074/jbc.274.19.13085

A. Burger, F. Dai, and C. Schultes, The G-Quadruplex-Interactive Molecule BRACO-19 Inhibits Tumor Growth, Consistent with Telomere Targeting and Interference with Telomerase Function, Cancer Research, vol.65, issue.4, pp.1489-1496, 2005.
DOI : 10.1158/0008-5472.CAN-04-2910

M. Kim, H. Vankayalapati, K. Shin-ya, K. Wierzba, and L. Hurley, Telomestatin, a Potent Telomerase Inhibitor That Interacts Quite Specifically with the Human Telomeric Intramolecular G-Quadruplex, Journal of the American Chemical Society, vol.124, issue.10, pp.2098-2099, 2002.
DOI : 10.1021/ja017308q

M. Sumi, T. Tauchi, and G. Sashida, A G-quadruplex-interactive agent, telomestatin (SOT- 095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia, Int J Oncol, vol.24, pp.1481-1487, 2004.

J. Zhou, X. Zhu, and Y. Lu, Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines, Oncogene, vol.362, pp.503-511, 2006.
DOI : 10.1038/sj.onc.1209067

J. Liu, R. Deng, and J. Guo, Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells, Leukemia, vol.25, issue.6, pp.1300-1302, 2007.
DOI : 10.1038/sj.onc.1209217

X. Wang, S. Wong, and J. Pan, Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells, Cancer Res, vol.58, pp.5019-5022, 1998.

H. Mese, Y. Ueyama, and A. Suzuki, Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line, Chemotherapy Int J Cancer, vol.47, issue.104, pp.136-142709, 2001.

S. Holt, D. Aisner, and J. Baur, Functional requirement of p23 and Hsp90 in telomerase complexes, Genes & Development, vol.13, issue.7, pp.817-826, 1999.
DOI : 10.1101/gad.13.7.817